Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Hawkins

Showing results (511-520 of 519) with videos related to

Pageof 52
Sort By:
You have reached the last page of results.This site can display upto 519 results.
The New England Journal of Medicine|July 31, 1998
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study GroupK G Saag, R Emkey, T J Schnitzer, et al.
Bone|October 22, 2013
Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label studyC Roux, L C Hofbauer, P R Ho, et al.
Journal of the American Veterinary Medical Association|April 8, 1998
Cobalt 60 radiotherapy for treatment of squamous cell carcinoma of the nasal cavity and paranasal sinuses in three horsesM A Walker, J Schumacher, D G Schmitz, et al.
Science (New York, N.Y.)|May 10, 2005
A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosisMichelle P Winn, Peter J Conlon, Kelvin L Lynn, et al.
Revista Clinica Espanola|June 12, 2003
[Calcaneous ultrasonography as measurement of osteoporosis prevalence in the general population in relation to the diagnostic criterion utilized. Data of the study GIUMO]M Sosa Henríquez, P Saavedra Santana, J Alegre López, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 7, 2013
Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosisP Farahmand, F Marin, F Hawkins, et al.
Calcified Tissue International|December 14, 1999
Bone mineral density and androgen levels in elderly malesA Rapado, F Hawkins, L Sobrinho, et al.
Cell|April 19, 1996
Identification and characterization of the mouse obesity gene tubby: a member of a novel gene familyP W Kleyn, W Fan, S G Kovats, et al.
Arthritis and Rheumatism|February 24, 2001
Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trialJ D Adachi, K G Saag, P D Delmas, et al.
Pageof 52

Showing results (511-520 of 519) with videos related to

Sort By:
Pageof 52
You have reached the last page of results.This site can display upto 519 results.
The New England Journal of Medicine|July 31, 1998
Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study GroupK G Saag, R Emkey, T J Schnitzer, et al.
Bone|October 22, 2013
Denosumab compared with risedronate in postmenopausal women suboptimally adherent to alendronate therapy: efficacy and safety results from a randomized open-label studyC Roux, L C Hofbauer, P R Ho, et al.
Journal of the American Veterinary Medical Association|April 8, 1998
Cobalt 60 radiotherapy for treatment of squamous cell carcinoma of the nasal cavity and paranasal sinuses in three horsesM A Walker, J Schumacher, D G Schmitz, et al.
Science (New York, N.Y.)|May 10, 2005
A mutation in the TRPC6 cation channel causes familial focal segmental glomerulosclerosisMichelle P Winn, Peter J Conlon, Kelvin L Lynn, et al.
Revista Clinica Espanola|June 12, 2003
[Calcaneous ultrasonography as measurement of osteoporosis prevalence in the general population in relation to the diagnostic criterion utilized. Data of the study GIUMO]M Sosa Henríquez, P Saavedra Santana, J Alegre López, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|June 7, 2013
Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosisP Farahmand, F Marin, F Hawkins, et al.
Calcified Tissue International|December 14, 1999
Bone mineral density and androgen levels in elderly malesA Rapado, F Hawkins, L Sobrinho, et al.
Cell|April 19, 1996
Identification and characterization of the mouse obesity gene tubby: a member of a novel gene familyP W Kleyn, W Fan, S G Kovats, et al.
Arthritis and Rheumatism|February 24, 2001
Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trialJ D Adachi, K G Saag, P D Delmas, et al.
Pageof 52